—

Caligan Partners LP

Q1 2026 13F Holdings

  • Location
    new york, NY
  • Num holdings

    28

  • Value ($000)

    $1,502,766

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001727492
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
L
LQDA

LIQUIDIA CORPORATION

COM NEW
53635D202
$306.41M
20 %

8,118,892

---

ABIVAX SA

SPONSORED ADS
00370M103
$162.79M
11 %

1,461,924

R
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$160.74M
11 %

1,652,808

P
PCVX

VAXCYTE INC

COM
92243G108
$119.75M
8 %

2,060,719

---

XENON PHARMACEUTICALS INC

COM
98420N105
$81M
5 %

1,393,027

M
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$75.11M
5 %

2,772,654

E
EX9

EXELIXIS INC

COM
30161Q104
$66.62M
4 %

1,553,262

C
CGON

CG ONCOLOGY INC

COM
156944100
$60.91M
4 %

900,000

call
T
TNGX

TANGO THERAPEUTICS INC

COM
87583X109
$50.39M
3 %

2,408,798

---

TYRA BIOSCIENCES INC

COM
90240B106
$48.91M
3 %

1,276,968

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 28